Nymox Pharmaceutical Corporation announced that the U.S. District Court for the Central District of California has granted the company's and Computershare Investor Services Inc.'s motion to dismiss a complaint filed by Christopher Riley. The case has been dismissed with prejudice, concluding the litigation.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Nymox Pharmaceutical Corporation published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001640334-25-001988), on November 07, 2025, and is solely responsible for the information contained therein.